Top

Archives of Gynecology and Obstetrics

Published in:

01-01-2013 | Reproductive Medicine

Does obesity compromise ovarian reserve markers? A clinician’s perspective

Authors: Neena Malhotra, Anupama Bahadur, Neeta Singh, Mani Kalaivani, Suneeta Mittal

Published in: Archives of Gynecology and Obstetrics | Issue 1/2013

Abstract

Objective

The aim of the study was to ascertain if increasing body mass index (BMI) adversely affects ovarian reserve among infertile women of Asian origin undergoing in vitro fertilization (IVF).

Materials and methods

This prospective study on 183 women was carried out in the infertility clinic of All India Institute of Medical Sciences, New Delhi, India. Blood hormonal assay in all patients including follicle-stimulating hormone (FSH), luteinizing hormone (LH) and inhibin B was performed on day 2/3 of a spontaneous cycle. A transvaginal ultrasonographic examination on day 2–5 of the menstrual cycle was done for antral follicle count (AFC) and ovarian volume. A correlation between BMI and ovarian reserve parameters like FSH, LH, inhibin B, antral follicle count and ovarian volume was noted.

Results

Age was comparable in the three BMI groups. The mean duration of infertility was 8.38 years. Compared to the normal weight, the overweight and obese women had a statistically significantly low inhibin B (p < 0.0259). The AFC when taken together on both sides was not statistically significant between the groups; however, the overweight and obese women had a significantly low AFC (p < 0.0129) on the right side.

Conclusion

Incorporating anti-mullerian hormone, a newer marker for ovarian reserve, may benefit these obese infertile women. Further work is required to elucidate the mechanisms underlying the effect of obesity on inhibin B as a marker of ovarian reserve in infertile women. The best marker to check the ovarian reserve is perhaps the woman’s performance during an IVF cycle. However, considering the psychological and financial stress of the procedure, it may seem wise to consider counseling of obese women on their expected performance in the first cycle of IVF through such studies.

Facts about overweight and obesity. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/index.html

Haslam DW, James WP (2005) Obesity. Lancet 366:1197–1209PubMedCrossRef

Metwally M, Li TC, Ledger WL (2007) The impact of obesity on female reproductive function. Obes Rev 8:515–523PubMedCrossRef

Gil-Campos M, Canete RR, Gil A (2004) Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23:963–974PubMedCrossRef

Spicer LJ (2001) Leptin A possible metabolic signal affecting reproduction. Domest Anim Endocrinol 21:251–270PubMedCrossRef

Brannian JD, Hansen KA (2002) Leptin and ovarian folliculogenesis: implications for ovulation induction and ART outcomes. Semin Reprod Med 20:103–112PubMedCrossRef

Moschos S, Chan JL, Mantzoros CS (2002) Leptin and reproduction: a review. Fertil Steril 77:433–444PubMedCrossRef

Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X et al (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10:2705–2712PubMedCrossRef

Shah DK, Missmer SA, Berry KF, Racowsky C, Ginsburg ES (2011) Effect of obesity on oocyte and embryo quality in women undergoing in vitro fertilization. Obstet Gynecol 118(1):63–70PubMedCrossRef

10.

Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T (2011) Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online 23(4):421–439PubMedCrossRef

11.

Wu LL, Norman RJ, Robker RL (2011) The impact of obesity on oocytes: evidence for lipotoxicity mechanisms. Reprod Fertil Dev 24(1):29–34PubMedCrossRef

12.

Poretsky L, Cataldo NA, Rosenwaks Z, Guidice LC (1999) The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20:535–582PubMedCrossRef

13.

Wang JX, Davies M, Norman RJ (2000) Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 321:1320–1321PubMedCrossRef

14.

Gonzalez F, Rote NS, Minium J, Kirwan JP (2006) Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:336–340PubMedCrossRef

15.

Agarwal A, Gupta S, Sharma RK (2005) Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3:28–49PubMedCrossRef

16.

Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB (2006) A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12:685–718PubMedCrossRef

17.

Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER (2005) The antral follicle count is a better marker then basal follicle stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization. Fertil Steril 83:811–814PubMedCrossRef

18.

Tinkanen H, Bläuer M, Laippala P, Tuohimaa P, Kujansuu E (2001) Correlation between serum Inhibin B and other indicators of the ovarian function. Eur J Obstet Gynecol Reprod Biol 94:109–113PubMedCrossRef

19.

Franchimont P, Hazeé-Hagelstein MT, Charlet-Renard C, Jaspar JM, Hazout A, Salat-Baroux J et al (1990) Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. II. Inhibin and aromatase inhibitor activity. J Clin Endocrinol Metab 71:748–754PubMedCrossRef

20.

Fowler PA, Fahy U, Culler MD, Knight PG, Wardle PG, McLaughlin EA et al (1995) Gonadotrophin surge-attenuating factor bioactivity is present in follicular fluid from naturally cycling women. Hum Reprod 10:68–74PubMedCrossRef

21.

De Pergola G, Maldera S, Tartagni M, Pannacciulli N, Loverro G, Giorgino R (2006) Inhibitory effect of obesity on gonadotropin, estradiol and Inhibin B levels in fertile women. Obesity 14(11):1954–1960PubMedCrossRef

22.

Cortet-Rudelli C, Pigny P, Decanter C, Leroy M, Maunoury-Lefebvre C, Thomas-Desrousseaux P, Dewailly D (2002) Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Fertil Steril 77(2):281–287PubMedCrossRef

23.

Popovic-Todorovic B, Loft A, Lindhard A, Bangsboll S, Andersson AM, Andersen AN (2003) A prospective study of predictive factors of ovarian response in ‘standard’ IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod 18:781–787PubMedCrossRef

24.

Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91PubMedCrossRef

25.

Cancello R, Clément K (2006) Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. Br J Obstet Gynaecol 113:1141–1147CrossRef

26.

Cnattingius S, Bergstrom R, Cnattingius L, Kramer MS (1998) Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 338:147–152PubMedCrossRef

27.

Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher NJ (2005) Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG 112:403–408PubMedCrossRef

28.

Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB, Olsen J (2005) Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet Gynecol 106:250–259PubMedCrossRef

29.

Balen AH, Dresner M, Scott EM, Drife JO (2006) Should obese women with polycystic ovary syndrome receive treatment for infertility? Br Med J 332:434–435 (Editorial)CrossRef

30.

Nelson SM, Fleming RF (2007) The preconceptual contraception paradigm: markers of inflammation and placental function throughout obesity and infertility. Hum Reprod 22:912–915PubMedCrossRef

31.

Seifer DB, Maclaughlin DT (2007) Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertil Steril 88:539–546PubMedCrossRef

Title: Does obesity compromise ovarian reserve markers? A clinician’s perspective
Authors: Neena Malhotra
Anupama Bahadur
Neeta Singh
Mani Kalaivani
Suneeta Mittal
Publication date: 01-01-2013
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 1/2013
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-012-2528-7

At a glance: The STEP trials

Springer Medicine

Does obesity compromise ovarian reserve markers? A clinician’s perspective

Abstract

Objective

Materials and methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2013

Early embryonic morphology sonographically assessed and its correlation with yolk sac in missed abortion

Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?

Consent for gynaecological procedure: what do women understand and remember?

Reviewers 2012

Thyroid (dys-)function in normal and disturbed pregnancy

Normal range for fetal urine production rate customized by biometry